Abstract
Objective
Priming solutions used during cardiopulmonary bypass may cause hemodilution, resulting in decreased perioperative hematocrit levels and increased transfusion requirements. This study aimed to evaluate the effects of retrograde autologous priming (ROP), particularly ROP volume, on hematocrit trajectory, red blood cell transfusion requirements, and clinical outcomes in patients undergoing isolated coronary artery bypass grafting (CABG).
Materials and Methods
Eighty adult patients who underwent isolated CABG were retrospectively analyzed. The patients were divided into two groups according to ROP use: ROP (-) (n = 40) and ROP (+) (n = 40). Demographic characteristics, perioperative variables, hematocrit levels, clinical outcomes, and red blood cell transfusion amounts were compared. ROP volume was recorded as a continuous variable. The Mann–Whitney U test, chi-square test, Spearman correlation, and multivariable linear regression analyses were used.
Results
The duration of mechanical ventilation was significantly shorter in the ROP (+) group (p = 0.023). The total red blood cell transfusion requirement was significantly lower in the ROP (+) group (median 1.0 vs. 3.5 units; p = 0.001). ROP volume was positively correlated with post–aortic cross-clamp hematocrit levels (ρ = 0.458; p < 0.001) and negatively correlated with total red blood cell transfusion amount (ρ = −0.298; p = 0.007). In the multivariable linear regression analysis, ROP volume remained independently associated with post–cross-clamp hematocrit levels (β = 0.232; p = 0.044).
Conclusion
ROP contributes to the preservation of post-bypass hematocrit levels and the reduction of red blood cell transfusion requirements in isolated CABG. The observed effect appears to depend not only on whether ROP is used but also on the volume of autologous blood applied.
Keywords:
Cardiopulmonary bypass, retrograde autologous priming, CABG, hemodilution, blood transfusion
References
1Kowalewski M, Pawliszak W, Raffa GM, Malvindi PG, Kowalkowska ME, Zaborowska K, et al. Safety and efficacy of miniaturized extracorporeal circulation when compared with off-pump and conventional coronary artery bypass grafting: evidence synthesis from a comprehensive Bayesian-framework network meta-analysis of 134 randomized controlled trials involving 22 778 patients. Eur J Cardiothorac Surg. 2016;49(5):1428-1440.
2Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944-982.
3Kesteven PJL. Haemostatic changes during cardiopulmonary bypass. Perfusion. 1990;5(1 Suppl):3-8.
4Sanaiha Y, Hadaya J, Verma A, Shemin RJ, Madani M, Young N, et al. Morbidity and mortality associated with blood transfusions in elective adult cardiac surgery. J Cardiothorac Vasc Anesth. 2023;37(9):1591-1598.
5Rosengart TK, DeBois W, O’Hara M, Helm R, Gomez M, Lang SJ, et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998;115(2):426-438; discussion 438-439.
6Kearsey C, Thekkudan J, Robbins S, Ng A, Lakshmanan S, Luckraz H. Assessing the effectiveness of retrograde autologous priming in isolated coronary artery bypass grafts. Ann R Coll Surg Engl. 2013;95(3):207-210.
7Hou X, Yang F, Liu R, Yang J, Zhao Y, Wan C, et al. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion in small adults: a prospective, randomized trial. Eur J Anaesthesiol. 2009;26(12):1061-1066.
8Koçoğlu Y, Memmedov S, Kayan E, Arkan B, Bozkaya TA, Özyüksel A, et al. Retrograde autologous priming for opposing the adverse effects of extracorporeal circulation during open heart surgery. Clin Surg. 2018;3(1):2004.
9Hofmann B, Kaufmann C, Stiller M, Neitzel T, Wienke A, Silber RE, et al. Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial. J Cardiothorac Surg. 2018;13(1):50.